SCHEMBL10082364

SCHEMBL10082364

Cc1ccc2c(-c3ccc(B(O)O)cc3)c3ccc(=[N+](C)C)cc-3oc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ BLM P54132 2/20 0.53
▸ THRB P10828 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ MAOB P27338 4/20 0.39
▸ USP2 O75604 4/20 0.38
▸ POLB P06746 3/20 0.38
▸ ATM Q13315 2/20 0.38
▸ PLEC Q15149 1/20 0.38
▸ P2RY6 Q15077 1/20 0.35
▸ CA2 P00918 1/20 0.34
▸ LPL P06858 1/20 0.34
▸ LIPG Q9Y5X9 1/20 0.34
▸ CSNK2A2 P19784 2/20 0.34
▸ CSNK2B P67870 2/20 0.34
▸ CSNK2A1 P68400 2/20 0.34
▸ ALPL P05186 1/20 0.33
▸ ALPI P09923 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12192021 0.85 MEN1 (0.74) MEN1KMT2ABLMTHRBRECQL
SCHEMBL16081224 0.73 MEN1 (0.57) MEN1KMT2ABLMTHRBRECQL
SCHEMBL10082262 0.73 MEN1 (0.48) MEN1KMT2ABLMTHRBRECQL
SCHEMBL10082363 0.71 USP2 (0.73) MEN1KMT2AMAOBUSP2POLB
SCHEMBL15488854 0.71 MEN1 (0.57) MEN1KMT2ABLMTHRBRECQL
SCHEMBL12332448 0.71 MEN1 (0.70) MEN1KMT2ABLMTHRBRECQL
SCHEMBL14533580 0.70 MEN1 (0.54) MEN1KMT2ABLMTHRBRECQL
SCHEMBL15488855 0.70 MEN1 (0.45) MEN1KMT2ABLMTHRBRECQL
SCHEMBL14013408 0.70 MEN1 (0.79) MEN1KMT2ABLMTHRBRECQL
SCHEMBL13525202 0.69 MEN1 (1.00) MEN1KMT2ABLMTHRBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140127137-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS Cercacor Laboratories, Inc (US) 2014-05-08 — — US disclosed
US-8466286-B2 SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors CERCACOR LABORATORIES, INC. (US) 2013-06-18 — — US disclosed
US-20120052018-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS MASIMO LABORATORIES, INC. (US) 2012-03-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140127137-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS GCKR, SYMPK, SUCNR1 MEN1 606/4885KMT2A 3286/4885BLM 2621/4885
US-20120052018-A1 SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS GCKR, SYMPK, SUCNR1 MEN1 606/4885KMT2A 3286/4885BLM 2621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback